Rafael Holdings AI Stock Analysis
Want to see RFL full AI Analyst Report?
Rafael Holdings (RFL) AI Stock Analysis
Rafael Holdings
(NYSE:RFL)
Overall score reflects (1) weak core profitability with persistent large losses and very small revenue, partially offset by (2) a low-debt balance sheet and a meaningful 2026 operating/free cash flow rebound. The stock’s technical trend is decisively bearish, while valuation is hard to support with negative earnings and no dividend. Positive corporate events (NDA submission and supportive subgroup Phase 3 data) help, but do not outweigh the earnings and trend risks.
Rafael Holdings (RFL) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $56.02M
- Dividend Yield
- ―
- Average Volume (3M)
- 143.86K
- Price to Earnings (P/E)
- -1.9
- Beta (1Y)
- 0.68
- Revenue Growth
- -4.69%
- EPS Growth
- 43.74%
- Country
- US
- Employees
- 21
- Sector
- Real Estate
- Sector Strength
- 65
- Industry
- Real Estate - Services
Rafael Holdings Business Overview & Revenue Model
Company Description
Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are struct...
How the Company Makes Money
Rafael Holdings generates earnings primarily through (1) real estate-related income from properties it owns and leases (e.g., rental revenue and related property income, net of operating expenses), and (2) investment-related gains/losses and income f...
Rafael Holdings Financial Statement Overview
Summary
Financials are mixed: the income statement is a major weakness with very small, declining revenue (~$0.87M in 2026, down ~10.8% YoY) and large ongoing losses (2026 net loss ~-$29.6M; deeply negative margins). Offsetting this, leverage is very low (2026 debt-to-equity ~0.01) and 2026 cash flow improved sharply with positive operating and free cash flow (~$14.3M each), though cash flow has been volatile across years and equity/assets declined materially from 2025 to 2026.
Income Statement
18Very NegativeBalance Sheet
63PositiveCash Flow
52Neutral| Breakdown | TTM | Jul 2026 | Jul 2025 | Oct 2024 | Jul 2023 | Oct 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 874.00K | 874.00K | 917.00K | 637.00K | 279.00K | 410.00K |
| Gross Profit | 578.00K | 628.00K | 495.00K | 483.00K | 279.00K | 410.00K |
| EBITDA | -28.67M | -33.20M | -32.25M | -66.79M | -8.67M | -139.89M |
| Net Income | -29.64M | -29.64M | -30.52M | -34.41M | -1.88M | -124.66M |
Balance Sheet | ||||||
| Total Assets | 83.06M | 83.06M | 114.11M | 96.83M | 98.83M | 118.32M |
| Cash, Cash Equivalents and Short-Term Investments | 22.07M | 22.07M | 52.77M | 65.94M | 79.51M | 63.23M |
| Total Debt | 610.00K | 610.00K | 692.00K | 2.39M | 0 | 15.00M |
| Total Liabilities | 11.09M | 11.09M | 15.74M | 10.57M | 2.20M | 21.11M |
| Stockholders Equity | 66.31M | 66.31M | 94.39M | 82.19M | 100.29M | 100.52M |
Cash Flow | ||||||
| Free Cash Flow | -29.98M | 14.32M | -18.93M | -7.98M | 40.79M | -26.08M |
| Operating Cash Flow | -29.98M | 14.32M | -18.92M | -7.80M | -10.89M | -26.08M |
| Investing Cash Flow | -676.00K | -676.00K | 44.03M | -10.82M | 21.21M | -63.80M |
| Financing Cash Flow | -128.00K | -116.00K | 24.83M | -179.00K | -15.22M | 103.86M |
Rafael Holdings Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RFL, the sentiment is Negative. The current price of 1.09 is below the 20-day moving average (MA) of 1.18, below the 50-day MA of 1.63, and below the 200-day MA of 1.67, indicating a bearish trend. The MACD of -0.15 indicates Negative momentum. The RSI at 35.25 is Neutral, neither overbought nor oversold. The STOCH value of 33.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RFL.
Rafael Holdings Risk Analysis
Rafael Holdings disclosed 78 risk factors in its most recent earnings report. Rafael Holdings reported the most risks in the "Tech & Innovation" category.
Latest Risks Added
3 New RisksRafael Holdings Peers Comparison
Overall Rating
COMP59Neutral
AGNT52Neutral
REAX52Neutral- RFL50Neutral
DOUG47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 65Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |
| COMP | 59Neutral | $7.67B | 52.48 | 5.49% | ― | 89.80% | ― |
| AGNT | 52Neutral | $476.85M | -18.58 | -9.51% | 7.03% | 7.72% | -22.43% |
| REAX | 52Neutral | $443.85M | -3.90 | -54.32% | ― | 32.27% | -463.00% |
| RFL | 50Neutral | $55.85M | -1.87 | -38.73% | ― | -4.69% | 43.74% |
| DOUG | 47Neutral | $157.35M | 2.75 | 32.79% | ― | -3.46% | ― |
* Real Estate Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RFL | Rafael Holdings | 1.09 | -0.17 | -13.49% | |
| AGNT | Exp World Holdings, Inc. | 2.85 | -7.70 | -73.01% | |
| REAX | Real Brokerage Inc. | 11.28 | -27.32 | -70.78% | |
| COMP | Compass Inc | 9.99 | 0.50 | 5.27% | |
| DOUG | Douglas Elliman Inc. | 1.74 | -0.76 | -30.40% |
Rafael Holdings Corporate Events
Rafael Holdings Submits NDA for Lead Rare Disease Drug
PositiveRafael Holdings reported results for the fourth quarter and full fiscal year ended July 31, 2026, highlighting progress across its portfolio despite continued losses. The company’s lead asset, remibetadex for Niemann-Pick Disease Type C, advanced wit...
Rafael Holdings Reports Positive Phase 3 Trappsol Cyclo Data
PositiveOn September 30, 2026, Rafael Holdings reported topline Phase 3 data from its TransportNPC study of Trappsol Cyclo in 94 Niemann‑Pick Disease Type C patients, showing a favorable but not statistically significant effect versus placebo on the primary...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 30, 2026